Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer
Clinical trial NCT05999812 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05999812
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2026-10-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.